8-K: TerrAscend Secures $79 Million Non-Dilutive Debt Upsize, Extends Maturity to 2028

Sentiment:

Debt Financing Update 9 July 2025 8:10 AM

TerrAscend Corp. has successfully closed a $79 million upsize to its senior secured term loan, primarily used to retire $68 million of existing debt and fund future growth initiatives, with no material debt maturing until late 2028.

Capital raiseTerrAscend completed a $79 million upsize to its existing senior-secured term loan (FG Loan).The financing is non-dilutive, meaning no new equity was issued.The upsized loan carries an interest rate of 12.75% and matures in August 2028.An additional uncommitted term loan facility of up to $35 million is available for future mergers and acquisitions.

Better than expectedThe company secured non-dilutive financing, which is generally preferred over equity raises as it avoids diluting existing shareholder value.The transaction extends the maturity profile of a significant portion of the company's debt to late 2028, reducing near-term refinancing risk.The proceeds were used to retire existing indebtedness, specifically the Pelorus Term Loan, which streamlines the debt structure and potentially reduces overall financing costs or improves terms.The additional capital provides flexibility for future growth initiatives and strategic mergers and acquisitions, positioning the company for expansion.

Summary

TerrAscend Corp. completed a $79 million upsize to its existing senior-secured term loan (the FG Loan) on July 8, 2025.
Of the $79 million drawn, $68 million was used to fully repay and terminate the Pelorus Term Loan and certain other indebtedness.
The remaining proceeds from the $79 million upsize are designated for future growth initiatives.
The upsized FG Loan carries an interest rate of 12.75% and matures in August 2028.
An additional uncommitted term loan facility of up to $35 million is available for future mergers and acquisitions (M&A).
The FG Loan contains no prepayment penalties and is guaranteed by TerrAscend Corp.
No warrants were issued as part of this debt financing.
Jason Wild, Executive Chairman of TerrAscend, a related party, invested approximately $1.6 million in the FG Loan as a member of the loan syndicate.

Sentiment

Score: 7

Explanation: The sentiment is positive due to the successful non-dilutive debt financing, which extends debt maturity, provides capital for growth, and retires existing debt. The high interest rate and related party involvement are minor tempering factors, but the overall financial restructuring is beneficial.

Positives

Secured $79 million in non-dilutive debt financing, avoiding equity dilution for shareholders.
Successfully retired $68 million of existing indebtedness, including the Pelorus Term Loan, improving the debt structure.
Extended the maturity of the vast majority of debt until late 2028, providing long-term financial stability.
Gained additional capital for future growth initiatives and strategic mergers and acquisitions (up to $35 million uncommitted facility).
The loan has no prepayment penalties, offering flexibility for future financial management.

Negatives

The interest rate of 12.75% on the upsized loan is relatively high, increasing interest expense.
The transaction involves a related party, Jason Wild, Executive Chairman, investing $1.6 million, which, while disclosed, can sometimes raise governance questions.

Risks

Cannabis remains a Schedule I drug under the U.S. Controlled Substances Act, making it illegal under federal law to cultivate, distribute, or possess cannabis in the United States.
Financial transactions involving proceeds from cannabis-related business activities in the U.S. may form the basis for prosecution under applicable U.S. federal money laundering legislation.
Strict compliance with state laws regarding cannabis does not absolve TerrAscend of liability under U.S. federal law, nor does it provide a defense to any federal proceeding.
The enforcement of federal laws in the United States is a significant risk that could adversely affect TerrAscend's operations and financial performance.
General risks related to current and future market conditions.
Risks related to federal, state, provincial, territorial, local, and foreign government laws, rules, and regulations, including those specific to cannabis operations.
Risks associated with the availability of licenses, approvals, and permits.

Future Outlook

TerrAscend expects future availability of funds under the uncommitted term loan facility for mergers and acquisitions and anticipates continued growth in both new and existing markets. The company aims to execute on its growth initiatives with the additional capital.

Management Comments

"This loan extends the vast majority of our debt until late 2028 and provides additional capital to execute on our growth initiatives, including M&A." Jason Wild, Executive Chairman of TerrAscend.
"This transaction reflects FocusGrowth's confidence in the Company's vision and strategy. Their team has been a pleasure to work with, and we look forward to a long and successful partnership together." Jason Wild, Executive Chairman of TerrAscend.
"Our team is excited to further our partnership with the TerrAscend team to support their growth." Peter Bio, Partner of FocusGrowth.
"TerrAscend has established itself as a market leader in multiple states with ample greenfield opportunities for growth in both new and existing markets. We have enjoyed working with the team on this transaction and are already working with management to evaluate additional opportunities." Peter Bio, Partner of FocusGrowth.

Industry Context

This debt financing occurs within the North American cannabis sector, where companies like TerrAscend operate across multiple U.S. states (Pennsylvania, New Jersey, Maryland, Ohio, Michigan, California) despite cannabis remaining federally illegal in the U.S. FocusGrowth Asset Management, LP, is highlighted as a leading capital provider specifically to the cannabis sector, indicating a specialized financing environment for this industry.

Comparison to Industry Standards

Corporate Governance

Change Type	Description	Effective Date	Impact Assessment
Related Party Transaction Exemption	The Company relied on exemptions from formal valuation and minority shareholder approval requirements of Multilateral Instrument 61-101 (MI 61-101) for Jason Wild's approximately US$1.6 million investment in the loan syndicate. This reliance was based on sections 5.5(a) and 5.7(1)(a) of MI 61-101, as the fair market value of the insider participation was below 25% of the Company's market capitalization.	July 8, 2025	Allows the related party transaction to proceed without extensive shareholder approval processes, streamlining the financing, but relies on specific regulatory exemptions.

Legal Proceedings

The document highlights the significant legal risk that cannabis remains a Schedule I drug under U.S. federal law, making it illegal. This could lead to federal prosecution for financial transactions involving cannabis proceeds, potentially adversely affecting TerrAscend's operations and financial performance.

Related Party Transactions

Jason Wild, Executive Chairman of TerrAscend, through funds he controls, invested approximately US$1.6 million in the upsized FG Loan as a member of the loan syndicate.

Stakeholder Impact

Shareholders: Benefit from non-dilutive financing, extended debt maturity, and capital for growth, potentially leading to increased shareholder value.
Creditors (FocusGrowth Asset Management, LP): Provided significant capital to TerrAscend, strengthening their partnership and indicating confidence in the company's strategy.
Employees: Potential for growth initiatives and M&A could lead to expansion and new opportunities.
Customers: Continued growth and M&A could lead to expanded product offerings or market presence.

Next Steps

The full text of the Amendment will be filed as an exhibit to the Company's Quarterly Report on Form 10-Q for the quarter ended June 30, 2025.
Management is already working with FocusGrowth to evaluate additional M&A opportunities.

Key Dates

Date	Description
October 11, 2022	Date of the original Pelorus Term Loan Agreement.
August 1, 2024	Date TerrAscend Corp. and TerrAscend USA, Inc. entered into the original $140 million senior-secured term loan (FG Loan).
September 30, 2024	Date of joinder agreement for WDB Holding MI, Inc. to the FG Loan.
March 6, 2025	Date TerrAscend's Annual Report for the year ended December 31, 2024, was filed with the SEC.
July 8, 2025	Date the Amendment for the $79 million upsize to the FG Loan was entered into and fully drawn; Pelorus Term Loan repaid in full and terminated.
July 9, 2025	Date the press release was issued regarding the Amendment and use of proceeds; Date the Form 8-K was signed.
June 30, 2025	Quarter end for which the Company's Quarterly Report on Form 10-Q will be filed, including the full text of the Amendment as an exhibit.
August 2028	Maturity date of the upsized senior secured syndicated term loan.

Recommendation

hold

Keywords

TerrAscend, debt financing, term loan, cannabis, M&A, Pelorus Term Loan, senior secured debt, non-dilutive, TSNDF, TSND, corporate finance, debt restructuring

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.